Sorrento And Mount Sinai To Jointly Develop COVI-SHIELD Antibody Therapy Targeting SARS-CoV-2 Infection (COVID-19) Read more
Recipharm secures supply of drug substance and commences manufacture of chloroquine phosphate Read more
Pfizer and BioNTech Dose First Participants in the U.S. as Part of Global COVID-19 mRNA Vaccine Development Program Read more
Gilead Announces Approval of Veklury (remdesivir) in Japan for Patients With Severe COVID-19 Read more
CluePoints Covid-19 Support Benefits Over 200 Clinical Studies Directly Affected By The Pandemic Read more
Lineage Cell Therapeutics Announces Early Exercise of Option with Cancer Research UK for Immuno-Oncology Cell Therapy Program Read more